ELIXIRGEN THERAPEUTICS Trademark

Trademark Overview


On Wednesday, December 1, 2021, a trademark application was filed for ELIXIRGEN THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the ELIXIRGEN THERAPEUTICS trademark a serial number of 97978846. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Friday, February 14, 2025. This trademark is owned by Elixirgen Therapeutics, Inc.. The ELIXIRGEN THERAPEUTICS trademark is filed in the Advertising, Business and Retail Services category with the following description:

Retail store services featuring pharmaceutical drugs and chemical preparations; retail store services featuring pharmaceutical drugs and chemical preparations for cell and gene therapy
elixirgen therapeutics

General Information


Serial Number97978846
Word MarkELIXIRGEN THERAPEUTICS
Filing DateWednesday, December 1, 2021
Status731 - SECOND EXTENSION - GRANTED
Status DateFriday, February 14, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, January 9, 2024

Trademark Statements


Description of MarkThe mark consists of the word "elixirgen" in small case letters with the portion "elixir" being in dark shade and the portion "gen" being in lighter shade; the word "THERAPEUTICS" in dark shade capital letters appearing in smaller font than, directly under, and of the same total length as, the "elixir" portion; and, to the left of both words, a three-lobed, intertwined infinity loop appears in dark shade, medium shade, and white.
Goods and ServicesRetail store services featuring pharmaceutical drugs and chemical preparations; retail store services featuring pharmaceutical drugs and chemical preparations for cell and gene therapy
NOT AVAILABLE"THERAPEUTICS"

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateWednesday, September 4, 2024
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameElixirgen Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBaltimore, MD 21205

Party NameElixirgen Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBaltimore, MD 21205

Trademark Events


Event DateEvent Description
Monday, September 19, 2022NON-FINAL ACTION WRITTEN
Saturday, December 4, 2021NEW APPLICATION ENTERED
Monday, December 6, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, December 7, 2021NOTICE OF DESIGN SEARCH CODE E-MAILED
Saturday, September 10, 2022ASSIGNED TO EXAMINER
Friday, February 3, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, February 3, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, December 4, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 20, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 5, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, September 19, 2022NON-FINAL ACTION E-MAILED
Monday, September 19, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, February 3, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, January 9, 2024PUBLISHED FOR OPPOSITION
Tuesday, January 9, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Friday, March 22, 2024TEAS REQUEST TO DIVIDE RECEIVED
Friday, March 22, 2024DIVISIONAL REQUEST RECEIVED
Friday, April 12, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, September 4, 2024DIVISIONAL PROCESSING COMPLETE
Wednesday, September 4, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, September 4, 2024SOU EXTENSION 1 FILED
Wednesday, September 4, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, September 4, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 12, 2025SOU EXTENSION 2 FILED
Wednesday, September 4, 2024SOU EXTENSION 1 GRANTED
Saturday, February 15, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 12, 2025SOU TEAS EXTENSION RECEIVED
Friday, February 14, 2025SOU EXTENSION 2 GRANTED